Panelists discuss how quality of life priorities shift in late-line multiple myeloma treatment, with patients emphasizing the ...

Panelists discuss how managing the logistics of multiple myeloma treatment often requires a comprehensive support network, ...

DelveInsight's "CARVYKTI Market Size, Forecast, and Market Insight Report" highlights the details around CARVYKTI, a ...

Longtime 95.5 WSB radio host Scott Slade has announced he has been diagnosed with multiple myeloma, a type of blood cancer ...

DelveInsight's "DARZALEX Market Size, Forecast, and Market Insight Report" highlights the details around DARZALEX, a human ...

Researchers sought to determine the significance of short-term blood pressure variability for assessing CTR-CVT in patients with multiple myeloma undergoing treatment with proteasome inhibitors.

The FDA has accepted the resubmitted BLA for linvoseltamab for patients with relapsed/refractory multiple myeloma.

Marianne says she is choosing to find the positives rather than the negatives since her diagnosis.

Why have BMS investors been anything but positive about acquiring 2seventy? The answer stems from uncertainty over how ...

In myeloma treatment, acute CRS is a common but treatable AE associated with CAR T-cell therapy and bispecific antibodies, ...

Ajai Chari, MD, University of California San Francisco, explores the challenges that accompany integrating chimeric antigen receptor (CAR) T-cell therapies into multiple myeloma treatment.